Skip to main content
BAXTER INTERNATIONAL INC logo

BAXTER INTERNATIONAL INC — Investor Relations & Filings

Ticker · BAX ISIN · US0718131099 LEI · J5OIVXX3P24RJRW5CK77 US Manufacturing
Open in API
Filings indexed 2,456 across all filing types
Latest filing 2019-05-10 Capital/Financing Update
Country US United States of America
Listing US BAX

About BAXTER INTERNATIONAL INC

https://www.baxter.com/

Baxter International Inc. is a global healthcare company focused on saving and sustaining lives. The company provides a broad portfolio of essential products across renal care, hospital, and surgical settings. Key offerings include technologies for acute and chronic dialysis, sterile intravenous (IV) solutions, infusion systems, clinical nutrition, and critical care. Baxter develops, manufactures, and markets a range of medical devices, connected care solutions, and advanced injectable pharmaceuticals. The company's products are used by healthcare professionals in hospitals, clinics, and homes to provide smarter, more personalized care for patients.

Recent filings

Filing Released Lang Actions
FWP
Capital/Financing Update Classification · 100% confidence The document is titled 'FINAL TERM SHEET' and is filed pursuant to Rule 433, which relates to free writing prospectuses used in securities offerings. It details the terms of senior notes issued by Baxter International Inc., including coupon rates, maturity dates, redemption options, ratings, and other issuance details. The content is focused on the specifics of a debt offering and financing terms rather than financial results, management changes, or regulatory compliance filings. This matches the description of a Capital/Financing Update, which covers company fundraising and capital structure changes. The document length is 7151 characters, sufficient to contain detailed financing information. There is no indication that this is an announcement of a report or a certification, so it is not an RPA or RNS. Therefore, the appropriate classification is Capital/Financing Update (CAP).
2019-05-10 English
424B5
Capital/Financing Update Classification · 100% confidence The document is a preliminary prospectus supplement filed pursuant to Rule 424(b)(5) under the Securities Act, related to an offering of senior notes by Baxter International Inc. It includes detailed terms of the debt securities offering, underwriting information, risk factors, and legal disclaimers. The document is a registration and offering prospectus supplement, not a financial report, earnings release, or management discussion. It is a capital markets document related to financing activities, specifically a debt issuance. Therefore, it fits the category of Capital/Financing Update (CAP). The document length is substantial and contains detailed offering terms, consistent with a financing update rather than a brief announcement or regulatory filing.
2019-05-10 English
8-K
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a Form 8-K filed with the SEC, dated May 7, 2019, reporting the results of the company's annual meeting of stockholders. It details the voting outcomes on director elections, executive compensation advisory vote, appointment of auditors, and stockholder proposals. The content is focused on the official results from shareholder votes at the annual general meeting. The document length is 4944 characters, which is sufficient to contain detailed voting results rather than just an announcement of a report. Therefore, this document fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA).
2019-05-10 English
PRIMARY DOCUMENT
Director's Dealing
2019-05-09 English
PRIMARY DOCUMENT
Director's Dealing
2019-05-09 English
PRIMARY DOCUMENT
Director's Dealing
2019-05-09 English

Browse filings by year

33 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.